SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias
about
Contribution of two-pore K+ channels to cardiac ventricular action potential revealed using human iPSC-derived cardiomyocytes.Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations.Positive Feedback Mechanisms among Local Ca Releases, NCX, and ICaL Ignite Pacemaker Action Potentials.
P2860
SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias
@en
SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias.
@nl
type
label
SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias
@en
SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias.
@nl
prefLabel
SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias
@en
SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias.
@nl
P2093
P2860
P356
P1476
SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias
@en
P2093
Asher Peretz
David Weisbrod
Edith Hochhauser
Hanna Bueno
Joachim Behar
Michael Eldar
Ofer Binah
Shiraz Haron-Khun
Yael Yaniv
P2860
P304
P356
10.15252/EMMM.201606937
P577
2017-04-01T00:00:00Z